Sirona Biochem Announces Addition of Dr. Brett Premack as Scientific Consultant
News Mar 15, 2012
Sirona Biochem Corp. has announced the appointment of Dr. Brett Premack as Scientific Consultant.
Dr. Premack will consult and advise on preclinical development activities, particularly pertaining to alliances between public and private research organizations.
"Dr. Brett Premack's expertise in drug discovery and preclinical development will bring tremendous value in the evaluation and development of our therapeutic portfolio," said Dr. Howard Verrico, President & CEO of Sirona Biochem.
"Our chemistry platform technology gives us several program options and our ability to attract high-calibre talent like Dr. Premack enables us to efficiently advance these programs," Dr. Verrico added.
Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of LondonNews
The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.READ MORE
A New Tactic in the Fight Against Drug-Resistant InfectionsNews
$1 million research grant could lead to life-saving antibiotics.READ MORE